Logo image of PPCB

PROPANC BIOPHARMA INC (PPCB) Stock Overview

USA - NASDAQ:PPCB - US74346N7012 - Common Stock

1.7 USD
-0.13 (-7.1%)
Last: 9/30/2025, 8:00:01 PM
1.6921 USD
-0.01 (-0.46%)
After Hours: 9/30/2025, 8:00:01 PM

PPCB Key Statistics, Chart & Performance

Key Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap21.44M
Shares12.61M
Float4.31M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-703.62
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO06-15 2012-06-15
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


PPCB short term performance overview.The bars show the price performance of PPCB in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

PPCB long term performance overview.The bars show the price performance of PPCB in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of PPCB is 1.7 USD. In the past month the price decreased by -37.73%.

PROPANC BIOPHARMA INC / PPCB Daily stock chart

PPCB Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.86 409.03B
AMGN AMGEN INC 12.94 151.93B
GILD GILEAD SCIENCES INC 14.34 137.73B
VRTX VERTEX PHARMACEUTICALS INC 23.12 100.41B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 59.77B
REGN REGENERON PHARMACEUTICALS 12.32 59.59B
ARGX ARGENX SE - ADR 79.56 45.14B
ONC BEONE MEDICINES LTD-ADR 5.95 40.50B
INSM INSMED INC N/A 30.44B
BNTX BIONTECH SE-ADR N/A 23.71B
NTRA NATERA INC N/A 22.09B
BIIB BIOGEN INC 8.75 20.54B

About PPCB

Company Profile

PPCB logo image Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The firm has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its lead product candidate, PRP, is a variation upon its formulation and involves pro-enzymes, the inactive precursors of enzymes. PRP is a long-term therapy based on a pancreatic proenzyme formulation to prevent tumor recurrence and metastasis. PRP is a patented, formulation consisting of two proenzymes mixed in a synergetic ratio. PRP is in the preclinical phase of development. Its drug pipeline also includes POP1.

Company Info

PROPANC BIOPHARMA INC

302/6 Butler Street, Camberwell

Melbourne VICTORIA AU

Employees: 2

PPCB Company Website

PPCB Investor Relations

Phone: 61398820780

PROPANC BIOPHARMA INC / PPCB FAQ

What is the stock price of PROPANC BIOPHARMA INC today?

The current stock price of PPCB is 1.7 USD. The price decreased by -7.1% in the last trading session.


What is the ticker symbol for PROPANC BIOPHARMA INC stock?

The exchange symbol of PROPANC BIOPHARMA INC is PPCB and it is listed on the Nasdaq exchange.


On which exchange is PPCB stock listed?

PPCB stock is listed on the Nasdaq exchange.


What is PROPANC BIOPHARMA INC worth?

PROPANC BIOPHARMA INC (PPCB) has a market capitalization of 21.44M USD. This makes PPCB a Nano Cap stock.


How many employees does PROPANC BIOPHARMA INC have?

PROPANC BIOPHARMA INC (PPCB) currently has 2 employees.


Should I buy PROPANC BIOPHARMA INC (PPCB) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PROPANC BIOPHARMA INC (PPCB) stock pay dividends?

PPCB does not pay a dividend.


What is the Price/Earnings (PE) ratio of PROPANC BIOPHARMA INC (PPCB)?

PROPANC BIOPHARMA INC (PPCB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-703.62).


What is the Short Interest ratio of PROPANC BIOPHARMA INC (PPCB) stock?

The outstanding short interest for PROPANC BIOPHARMA INC (PPCB) is 4.37% of its float. Check the ownership tab for more information on the PPCB short interest.


PPCB Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to PPCB.


Chartmill TA Rating
Chartmill Setup Rating

PPCB Financial Highlights

Over the last trailing twelve months PPCB reported a non-GAAP Earnings per Share(EPS) of -703.62. The EPS increased by 98.43% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -2147.26%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%97.92%
Sales Q2Q%N/A
EPS 1Y (TTM)98.43%
Revenue 1Y (TTM)N/A

PPCB Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

PPCB Ownership

Ownership
Inst Owners9.97%
Ins Owners67.52%
Short Float %4.37%
Short Ratio0.3